citarinostat and its Impurities

Citarinostat is an oral, selective histone deacetylase 6 inhibitor that inhibits growth of solid tumor cell lines and exhibits potent synergy with Pac in preclinical studies. It is under investigation in clinical trial NCT02886065.. Reference standards of Citarinostat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below